Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2006 pubmed 114 citations

Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide.

Mookherjee. Neeloffer N; Wilson. Heather L HL; Doria. Silvana S; Popowych. Yurij Y; Falsafi. Reza R; Yu. Jie Jessie JJ; Li. Yuexin Y; Veatch. Sarah S; Roche. Fiona M FM; Brown. Kelly L KL; Brinkman. Fiona S L FS; Hokamp. Karsten K; Potter. Andy A; Babiuk. Lorne A LA; Griebel. Philip J PJ; Hancock. Robert E W RE

Key Findings

  • LL‑37 and BMAP‑27 suppress LPS‑induced gene activation in human and bovine monocytes at 5 µg/ml
  • Both peptides prevent NF‑κB subunits p50 and p65 from moving into the nucleus, reducing inflammation
  • BMAP‑27 alone can affect some inflammatory genes more than LL‑37, showing species‑specific differences

Practical Outcomes

  • LL‑37 may be useful as a low‑dose supplement to blunt acute inflammatory spikes from bacterial endotoxins, potentially supporting immune balance and longevity. However, the study does not provide dosing guidelines, safety data, or delivery methods, so further research is needed before practical protocols can be recommended.

Summary

The study shows that the natural peptide LL‑37 (and its cow version BMAP‑27) can strongly dampen the inflammatory response that cells have to bacterial toxins, even at low doses that could be reached in the body. This anti‑inflammatory effect works by blocking the activation of NF‑κB, a key driver of inflammation.

Abstract

Genomic approaches can be exploited to expose the complexities and conservation of biological systems such as the immune network across various mammalian species. In this study, temporal transcriptional expression profiles were analyzed in human and bovine monocytic cells in response to the TLR-4 agonist, LPS, in the presence or absence of their respective host defense peptides. The cathelicidin peptides, human LL-37 and bovine myeloid antimicrobial peptide-27 (BMAP-27), are homologs, yet they have diverged notably in terms of sequence similarity. In spite of their low sequence similarities, both of these cathelicidin peptides demonstrated potent, antiendotoxin activity in monocytic cells at low, physiologically relevant concentrations. Microarray studies indicated that 10 ng/ml LPS led to the up-regulation of 125 genes in human monocytes, 106 of which were suppressed in the presence of 5 mug/ml of the human peptide LL-37. To confirm and extend these data, temporal transcriptional responses to LPS were assessed in the presence or absence of the species-specific host defense peptides by quantitative real-time PCR. The transcriptional trends of 20 LPS-induced genes were analyzed in bovine and human monocytic cells. These studies demonstrated conserved trends of gene responses in that both peptides were able to profoundly suppress many LPS-induced genes. Consistent with this, the human and bovine peptides suppressed LPS-induced translocation of NF-kappaB subunits p50 and p65 into the nucleus of monocytic cells. However, there were also distinct differences in responses to LPS and the peptides; for example, treatment with 5 mug/ml BMAP-27 alone tended to influence gene expression (RELA, TNF-alpha-induced protein 2, MAPK phosphatase 1/dual specificity phosphatase 1, IkappaBkappaB, NFkappaBIL1, TNF receptor-associated factor 2) to a greater extent than did the same amount of human LL-37. We hypothesize that the immunomodulatory effects of the species-specific host defense peptides play a critical role in regulating inflammation and represent an evolutionarily conserved mechanism for maintaining homeostasis, although the sequence divergence of these peptides is substantial.

Study Information

Provider

pubmed

Year

2006

Date

2006-08-30T00:00:00.000Z

DOI

10.1189/jlb.0106048

Citations

114

References

50